Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 134.71M | $ 18.77M | $ 115.94M | $ 0 |
3/31/2025 | $ 150.7M | $ 73.87M | $ 76.83M | $ 0 |
12/31/2024 | $ 70.09M | $ 37.11M | $ 32.99M | $ 0 |
9/30/2024 | $ 88.43M | $ 35.44M | $ 52.98M | $ 0 |
6/30/2024 | $ 108.81M | $ 45.15M | $ 63.66M | $ 0 |
3/31/2024 | $ 127.9M | $ 24.37M | $ 103.53M | $ 0 |
12/31/2023 | $ 151.53M | $ 135.77M | $ 15.75M | $ 0 |
9/30/2023 | $ 85.85M | $ 70.5M | $ 15.35M | $ 0 |
6/30/2023 | $ 106.13M | $ 90.87M | $ 15.26M | $ 0 |
3/31/2023 | $ 121.74M | $ 79.07M | $ 42.67M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ALIGOS THERAPEUTICS INC is calculated as follows: Assets [ $ 92.18M ] - Intangibles [ $ 0 ] - CashnEq [ $ 32.37M ]
(=) Core Assets [ $ 59.81M ]
Minimum
Jun 30, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.42B |
average | $ 803.6M |
median | $ 289.12M |
std | $ 1.06B |